Hundreds of women with advanced cervical cancer in England are set to benefit from a new NHS treatment that could significantly improve survival rates and help keep the disease from returning. The immunotherapy drug pembrolizumab has been approved for NHS use in combination with standard chemoradiotherapy for patients with stages three and four locally advanced … Continue reading NHS rolls out new immunotherapy for women with advanced cervical cancer